Advertisement
Screener

BIOCERES CROP SOLUTIONS CORP. (BIOX) Accounting Profit

2.8 / 5 stars · 68/120 Roast Me

BIOCERES CROP SOLUTIONS CORP. Accounting Profit

BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Accounting Profit of -$1.37 million for the 3-month period ending 2025-12-31, per its 6-K filed 2026-03-13.

Financial Statements › Notes

ifrs-full:AccountingProfit · last filed 2026-03-13

  • BIOCERES CROP SOLUTIONS CORP. accounting profit for the quarter ending 2025-12-31 was -$1.37M, a 118.71% decline year-over-year.
  • BIOCERES CROP SOLUTIONS CORP. accounting profit for the quarter ending 2025-09-30 was -$5.37M.
  • BIOCERES CROP SOLUTIONS CORP. accounting profit for the quarter ending 2025-06-30 was -$44.92M.
  • BIOCERES CROP SOLUTIONS CORP. accounting profit for the quarter ending 2025-03-31 was -$5.60M, a 163.45% decline year-over-year.
Period endAccounting Profit 3 monthAccounting Profit 3 month as first filedAccounting Profit 6 monthAccounting Profit 6 month as first filedAccounting Profit 9 monthAccounting Profit 12 monthAccounting Profit 12 month as first filed
2025-12-31-$1.37M
6-K · filed 2026-03-13
-$3.63M
6-K · filed 2026-03-13
-$51.65M
derived: sum of 3 quarters · filed 2026-03-13
-$57.24M
derived: sum of 4 quarters · filed 2026-03-13
2025-09-30-$5.37M
6-K · filed 2025-11-26
-$50.28M
derived: sum of 2 quarters · filed 2025-11-26
-$55.88M
derived: sum of 3 quarters · filed 2025-11-26
-$48.58M
derived: sum of 4 quarters · filed 2026-03-13
2025-06-30-$44.92M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
-$50.51M
derived: sum of 2 quarters · filed 2025-11-10
-$43.21M
derived: sum of 3 quarters · filed 2026-03-13
-$57.57M
20-F · filed 2025-11-10
2025-03-31-$5.60M
6-K · filed 2025-06-20
$1.70M
derived: sum of 2 quarters · filed 2026-03-13
-$12.66M
6-K · filed 2025-06-20
-$10.84M
derived: sum of 4 quarters · filed 2026-03-13
2024-12-31$7.30M
6-K · filed 2026-03-13
$406.15K
6-K · filed 2025-02-28
$2.63M
6-K · filed 2026-03-13
-$7.06M
6-K · filed 2025-02-28
-$5.24M
derived: sum of 3 quarters · filed 2026-03-13
$3.58M
derived: sum of 4 quarters · filed 2026-03-13
2024-09-30-$7.46M
6-K · filed 2025-11-26
-$12.54M
derived: sum of 2 quarters · filed 2025-11-26
-$3.72M
derived: sum of 3 quarters · filed 2025-11-26
$5.85M
derived: sum of 4 quarters · filed 2025-11-26
2024-06-30-$5.08M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
$3.75M
derived: sum of 2 quarters · filed 2025-11-10
$13.32M
derived: sum of 3 quarters · filed 2025-11-10
$11.07M
20-F · filed 2025-11-10
$10.04M
20-F · filed 2024-10-30
2024-03-31$8.82M
6-K · filed 2025-06-20
$18.39M
derived: sum of 2 quarters · filed 2025-06-20
$16.14M
6-K · filed 2025-06-20
$11.78M
derived: sum of 4 quarters · filed 2025-11-10
2023-12-31$9.57M
6-K · filed 2025-02-28
$7.32M
6-K · filed 2025-02-28
$2.96M
derived: sum of 3 quarters · filed 2025-11-10
$25.25M
derived: sum of 4 quarters · filed 2025-11-10
2023-09-30-$2.25M
6-K · filed 2024-11-27
-$6.62M
derived: sum of 2 quarters · filed 2025-11-10
$15.67M
derived: sum of 3 quarters · filed 2025-11-10
$7.93M
derived: sum of 4 quarters · filed 2025-11-10
2023-06-30-$4.37M
derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10
$17.92M
derived: sum of 2 quarters · filed 2025-11-10
$10.18M
derived: sum of 3 quarters · filed 2025-11-10
$19.11M
20-F · filed 2025-11-10
2023-03-31$22.29M
derived: 6-K 9 month − 6-K 6 month · filed 2024-05-29
$14.55M
derived: sum of 2 quarters · filed 2024-05-29
$23.47M
6-K · filed 2024-05-29
2022-12-31-$7.74M
derived: 6-K 6 month − 6-K 3 month · filed 2024-02-28
$1.18M
6-K · filed 2024-02-28
2022-09-30$8.92M
6-K · filed 2023-11-29
2022-06-30$14.06M
20-F · filed 2024-10-30